Cancellations requested by the sponsor - regulatory actions

Sponsors can submit requests to cancel entries in the Australian Register of Therapeutic Goods (ARTG). The Therapeutic Goods Act 1989 (the Act) requires the TGA to publish information on the Secretary’s decision to action these cancellations.

The cancellation provisions relating to cancellations requested by the sponsor in the Act are:

  • cancellation of listed or registered therapeutic goods: section 30(1)(c)
  • cancellation of biologicals: section 32GA(1)(d)
  • cancellation of medical devices: section 41GL(d).

The records below include information on the cancellation decisions and any subsequent decisions to revoke such cancellations. To find out whether a product is currently authorised for supply in Australia, check the ARTG.

Enter a product name or an ARTG number.

Cancellations

Displaying 1 - 10 of 19776

Generic Partners Pty Ltd

Product: CORALIVAN ivabradine (as hydrochloride) 5 mg tablet blister pack

ARTG number: 285497

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Generic Partners Pty Ltd

Product: CORALIVAN ivabradine (as hydrochloride) 7.5 mg tablet blister pack

ARTG number: 285490

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Cipla Australia Pty Ltd

Product: IMATINIB AN imatinib (as mesilate) 400 mg capsules blister pack

ARTG number: 281366

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Cipla Australia Pty Ltd

Product: IMATINIB AN imatinib (as mesilate) 100 mg capsules blister pack

ARTG number: 281365

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Eli Lilly Australia Pty Ltd

Product: TRENUVIS pemetrexed (as disodium) 500mg powder for injection vial

ARTG number: 228302

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Eli Lilly Australia Pty Ltd

Product: TRENUVIS pemetrexed (as disodium) 100 mg powder for injection vial

ARTG number: 228301

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Cipla Australia Pty Ltd

Product: PHARMACY CARE IBUPROFEN PLUS CODEINE film-coated tablet blister pack

ARTG number: 227476

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Sandoz Pty Ltd

Product: SANDOZ COLD & FLU PE DAY AND NIGHT tablets blister pack

ARTG number: 222849

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Sandoz Pty Ltd

Product: GABAPENTIN GH gabapentin 300 mg capsule blister pack

ARTG number: 219923

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Sandoz Pty Ltd

Product: GABAPENTIN GH gabapentin 400 mg capsule blister pack

ARTG number: 219922

Type of decision: Cancelled under Section 30(1)(c) of the Act

Date of effect: 29 Jun 2018

Pages